Spots Global Cancer Trial Database for breast neoplasms
Every month we try and update this database with for breast neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Registry Study of Breast Microseed Treatment | NCT02701244 | Breast Neoplasm... | Permanent Breas... | 50 Years - | Concure Oncology-Breast Microseed Inc. | |
| Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) | NCT03099031 | Venous Thromboe... | Tinzaparin | 18 Years - | LEO Pharma | |
| Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer | NCT00908531 | Operable Breast... | letrozole (Fema... | 60 Years - | Danish Breast Cancer Cooperative Group | |
| A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT) | NCT00187343 | Breast Neoplasm... | Breast IMRT | - | Sunnybrook Health Sciences Centre | |
| Decision Aids for Tamoxifen Treatment in Breast Cancer Patients | NCT02488603 | Breast Cancer | Decision aids (... tamoxifen | 18 Years - | National Cancer Center, Korea | |
| Personalized Breast Cancer Screening | NCT06060938 | Breast Cancer | Risk stratified... Control arm | 50 Years - 67 Years | Herlev and Gentofte Hospital | |
| Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy | NCT02003599 | Radiotherapy; A... Breast Neoplasm... | Laser therapy Placebo | 30 Years - 70 Years | Universidade do Vale do Sapucai | |
| A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer | NCT00246597 | Anemia Breast Neoplasm... Hemoglobins Quality of Life Chemotherapy, A... | epoetin alfa | 18 Years - | Ortho Biotech Products, L.P. | |
| Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) | NCT04964934 | ER-Positive HER... | AZD9833 AZD9833 Placebo Anastrozole Anastrozole pla... Letrozole Letrozole place... Palbociclib Abemaciclib Luteinizing hor... Ribociclib | 18 Years - 130 Years | AstraZeneca | |
| A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) | NCT00600496 | Breast Cancer Breast Neoplasm... Colon Cancer Colonic Cancer Colon Neoplasms Lung Cancer Melanoma Kidney Cancer | AZD6244 Dacarbazine Erlotinib Docetaxel Temsirolimus | 18 Years - 130 Years | AstraZeneca | |
| App for Adverse Events to Oral Chemotherapy - Pilot Study | NCT05743686 | Breast Neoplasm... Chemotherapeuti... | Application | 18 Years - | CHU de Quebec-Universite Laval | |
| Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer | NCT05386108 | Breast Neoplasm... Brain Neoplasms Neoplasms by Si... Neoplasms Breast Diseases Central Nervous... Brain Diseases Central Nervous... | Elacestrant Abemaciclib | 18 Years - | Stemline Therapeutics, Inc. | |
| Impact of Acceptance and Commitment Therapy on Early Stage Breast Cancer | NCT01164930 | Breast Neoplasm... Survivorship Stress | Acceptance and ... | - | San Jose State University | |
| Ultrasound Elastography of Breast Lesions | NCT00716482 | Breast Neoplasm... | 21 Years - | SuperSonic Imagine | ||
| The Ultrasound Study of Tamoxifen | NCT01582074 | Breast Neoplasm... | 30 Years - 70 Years | National Institutes of Health Clinical Center (CC) | ||
| A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease | NCT04711252 | ER-Positive HER... | AZD9833 Anastrozole Anastrozole pla... AZD9833 placebo Palbociclib Luteinizing hor... | 18 Years - 130 Years | AstraZeneca | |
| Health Education for Women With Breast Cancer | NCT05873296 | Breast Cancer F... | Health Educatio... | 18 Years - 65 Years | Federal University of Maranhao | |
| Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane | NCT00036270 | Breast Neoplasm... | exemestane (Aro... tamoxifen + exe... | 50 Years - | Pfizer | |
| Phase 2 Study of TLK286 in Metastatic Breast Cancer | NCT00035841 | Breast Neoplasm... | TLK286 | 18 Years - | Telik | |
| PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer | NCT01723774 | Breast Neoplasm... | PD0332991 Anastrozole Goserelin Surgery (standa... Tumor biopsy | 18 Years - | Washington University School of Medicine | |
| Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... | NCT02484404 | Colorectal Neop... Breast Neoplasm... | Olaparib Cediranib Durvalumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis | NCT02249884 | Radiodermatitis | Urea Dose A Urea Dose B Urea Dose C Chamomile Dose ... Chamomile Dose ... Chamomile Dose ... | 18 Years - | University of Brasilia | |
| Nurse-led Care Program for Cancer Patients in Chemotherapy Day Center | NCT02228200 | Breast Neoplasm... Colorectal Neop... | Nurse-led care Routine care | 18 Years - | The Hong Kong Polytechnic University | |
| Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer | NCT00546364 | Breast Neoplasm... | Ixabepilone, 40... Ixabepilone, 32... Docetaxel, 75 m... | 18 Years - | R-Pharm | |
| Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment | NCT00605267 | Breast Cancer | Tamoxifen Anastrazole (Ar... Goserelin aceta... | 20 Years - | AstraZeneca | |
| Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ | NCT04722692 | DCIS Breast Cancer Breast Neoplasm... Sentinel Lymph ... | Delayed SLND Late SLND | 18 Years - | Uppsala University | |
| Health Education for Women With Breast Cancer | NCT05873296 | Breast Cancer F... | Health Educatio... | 18 Years - 65 Years | Federal University of Maranhao | |
| A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases | NCT03500380 | Breast Neoplasm... Breast Diseases Capecitabine HER2-positive B... HER2 Positive B... HER2-positive A... | RC48-ADC Lapatinib Capecitabine | 18 Years - 70 Years | RemeGen Co., Ltd. | |
| Raloxifene Use for The Heart | NCT00190593 | Cardiovascular ... Breast Neoplasm... | raloxifene placebo | 55 Years - | Eli Lilly and Company | |
| A Trial of a New Magnetic Breast Marking Clip | NCT02378558 | Breast Neoplasm... | MagneMarker | 18 Years - | Maimonides Medical Center | |
| Reader Study for Image Quality of Cone Beam Breast CT System | NCT02864667 | Breast Neoplasm... | 35 Years - | Koning Corporation | ||
| LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment | NCT01125566 | Breast Neoplasm... | BIBW 2992 trastuzumab vinorelbine vinorelbine | 18 Years - | Boehringer Ingelheim | |
| Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution | NCT06379880 | Prostatic Neopl... Lung Neoplasms Breast Neoplasm... Colorectal Neop... | CONTINUUM+ CONN... | 18 Years - | Institut de cancérologie Strasbourg Europe | |
| A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer. | NCT00471159 | Breast Neoplasm... | docetaxel PF-3512676 | 18 Years - | Pfizer | |
| An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study) | NCT05263362 | Breast Fibrosis Breast Cancer Breast Cancer F... Breast Neoplasm... Breast Carcinom... Breast Carcinom... | no intervention | 18 Years - | Erasmus Medical Center | |
| Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer | NCT00210236 | Breast Cancer | Conventional su... | 50 Years - | Institut Bergonié | |
| Exercise in Women at Risk for Breast Cancer | NCT00092950 | Breast Neoplasm... | Physical activi... | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients | NCT04608357 | Breast Cancer Breast Neoplasm... Metastatic Brea... Cancer, Breast | Needle Core Bio... | 18 Years - | Sunnybrook Health Sciences Centre | |
| The Synergism Or Long Duration (SOLD) Study | NCT00593697 | Breast Neoplasm... | trastuzumab (9 ... trastuzumab (9 ... | 18 Years - | Finnish Breast Cancer Group | |
| Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) | NCT01231022 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | ||
| Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment | NCT06234150 | Breast Neoplasm... Exercise Therap... Chemotherapy-Re... Cognitive Dysfu... Dance Therapy | Aerobic dance Fast-walking | 18 Years - 65 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer | NCT00281528 | Breast Neoplasm... Neoplasm Metast... | ABI-007 (Abraxa... bevacizumab | 18 Years - | Celgene | |
| Korea Post Marketing Surveillance (PMS) Study of Talzenna® | NCT04982848 | Breast Neoplasm... | Talzenna | 19 Years - | Pfizer | |
| Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer | NCT03435380 | Breast Neoplasm... Early Detection... | Patient activat... Primary care ph... Control | 25 Years - | Duke University | |
| PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) | NCT00043368 | Melanoma Breast Neoplasm... Carcinoma, Rena... Lymphoma, T-Cel... Carcinoma, Non-... | PF-3512676 | 18 Years - | Pfizer | |
| Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube in Modified Radical Mastectomy on Breast Cancer | NCT00638599 | Breast Cancer | LMA® Endotracheal tu... | 18 Years - 70 Years | Nanjing Medical University | |
| A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer | NCT00001378 | Breast Cancer Breast Neoplasm... | fenretinide | - | National Institutes of Health Clinical Center (CC) | |
| Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy | NCT00146536 | Breast Neoplasm... | 20 Years - | Dana-Farber Cancer Institute | ||
| A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer | NCT00417885 | Breast Neoplasm... | exemestane sunitinib malat... | 18 Years - | Pfizer | |
| Reversing Therapy Resistance With Epigenetic-Immune Modification | NCT02395627 | Breast Neoplasm... | Tamoxifen Vorinostat Pembrolizumab | 18 Years - | University of California, San Francisco | |
| Exercise and Radiotherapy, a Good Combination? | NCT01908023 | Breast Neoplasm... | exercise | 18 Years - 80 Years | Norwegian University of Science and Technology | |
| The Value of High-resolution Ultrasound in the Detection of Lymph Node Metastasis: a Proposal of NI-RADS | NCT03791840 | Breast Neoplasm... | Ultrasound eval... | 18 Years - 90 Years | Peking University People's Hospital | |
| Delaying the Superficial Inferior Epigastric Artery (SIEA) Flap and Determining the Change in SIEA Diameter and Blood Flow | NCT01247129 | Breast Neoplasm... | Delay procedure... | 18 Years - 80 Years | University Medical Centre Ljubljana | |
| Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer | NCT00437359 | Breast Neoplasm... | Toremifene citr... Anastrozole | - | Japan Breast Cancer Research Network | |
| Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up | NCT01357772 | Carcinoma, Intr... Recurrence, Loc... Breast Neoplasm... Atypical Hyperp... | Tamoxifen placebo | 18 Years - 75 Years | Ente Ospedaliero Ospedali Galliera | |
| Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning Study | NCT01284153 | Breast Neoplasm... Radiation | - | Universitaire Ziekenhuizen KU Leuven | ||
| The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients | NCT05146843 | Breast Neoplasm... | Mitoquinone Placebo | 18 Years - 75 Years | D'Or Institute for Research and Education | |
| Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast Cancer | NCT03461588 | Breast Neoplasm... Heart Injuries Radiation Toxic... | free-breathing deep inspirator... | 18 Years - 70 Years | ChineseAMS | |
| Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ | NCT04722692 | DCIS Breast Cancer Breast Neoplasm... Sentinel Lymph ... | Delayed SLND Late SLND | 18 Years - | Uppsala University | |
| German Preoperative Adriamycin Docetaxel Study | NCT00543829 | Breast Neoplasm... | doxorubicin, do... doxorubicin, do... | 18 Years - 70 Years | German Breast Group | |
| A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | NCT01344109 | Breast Neoplasm... | 18 Years - | Leo W. Jenkins Cancer Center | ||
| Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients | NCT01686737 | Breast Neoplasm... Fatigue | Iyengar Yoga Walking | 18 Years - | Universität Duisburg-Essen | |
| A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer | NCT05584644 | Breast Cancer Breast Carcinom... Breast Neoplasm... Breast Tumors Cancer of Breas... | Palbociclib plu... Palbociclib plu... | 18 Years - 99 Years | Pfizer | |
| Breast Cancer, Reasoning, and Activity Intervention | NCT04816006 | Breast Cancer Breast Neoplasm... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Cancer-related ... | Aerobic Exercis... Health Educatio... Magnetic Resona... Medical Device ... Gait Assessment | 18 Years - | Mayo Clinic | |
| Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter Trial | NCT01524029 | Breast Neoplasm... | 25 Years - | Medical University of Vienna | ||
| Hemostatic Profiles of Endocrine Therapies for Breast Cancer | NCT03381963 | Breast Neoplasm... Venous Thromboe... | 18 Years - | University Hospital, Geneva | ||
| Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients | NCT01786122 | Non-Small-Cell ... Digestive Syste... Breast Neoplasm... | Supervised Phys... education progr... | 18 Years - 70 Years | Basque Health Service | |
| A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer | NCT03280563 | Breast Neoplasm... | Atezolizumab (M... Bevacizumab Entinostat Exemestane Fulvestrant Ipatasertib Tamoxifen Abemaciclib | 18 Years - | Hoffmann-La Roche | |
| A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer | NCT04528225 | Breast Neoplasm... Hypothyroidism Radiation Toxic... | 18 Years - 70 Years | ChineseAMS | ||
| DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast | NCT04052893 | Breast Neoplasm... | Expanded Mckiss... Modified radica... | 45 Years - 75 Years | Shengjing Hospital | |
| Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer | NCT00325598 | Breast Neoplasm... | Partial Breast ... | 18 Years - | Washington University School of Medicine | |
| ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid | NCT02218385 | Breast Neoplasm... | ForeCYTE Breast... | 20 Years - 75 Years | Atossa Therapeutics, Inc. | |
| Reversing Therapy Resistance With Epigenetic-Immune Modification | NCT02395627 | Breast Neoplasm... | Tamoxifen Vorinostat Pembrolizumab | 18 Years - | University of California, San Francisco | |
| Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane | NCT00036270 | Breast Neoplasm... | exemestane (Aro... tamoxifen + exe... | 50 Years - | Pfizer | |
| Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer | NCT02690480 | Breast Neoplasm... | PD-0332991 (Pal... Fulvestrant Placebo | 18 Years - | Spanish Breast Cancer Research Group | |
| Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer | NCT01953445 | Breast Neoplasm... | paclitaxel BKM120 | 18 Years - | Washington University School of Medicine | |
| Focused Ultrasound and Gemcitabine in Breast Cancer | NCT04796220 | Breast Cancer Breast Neoplasm... | Gemcitabine Focused Ultraso... Gemcitabine and... | 18 Years - | University of Virginia | |
| Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation | NCT00926315 | Breast Neoplasm... Postmenopausal ... | calcitriol Calcitriol | 40 Years - 70 Years | University of Sao Paulo General Hospital | |
| Biennial CEM in Women With a Personal History of Breast Cancer | NCT06105749 | Breast Cancer Breast Neoplasm... Breast Cancer F... Neoplasms | contrast-enhanc... | 30 Years - 79 Years | University of Pittsburgh | |
| Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib | NCT01875666 | Breast Neoplasm... | Trastuzumab pertuzumab lapatinib | 18 Years - | UNC Lineberger Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
